Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00146588 Information provided by Dana-Farber Cancer Institute

First Received: September 6, 2005 Last Updated: August 24, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2008
Primary Completion Date:	September 2004 (Final data collection date for primary outcome measure)